1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Life Science and Chemical Instrumentation Market - Global Forecast to 2019

The global life science and chemical instrumentation market is estimated to grow at a CAGR of 6.9% from 2014 to 2019. Although mature markets (such as the U.S., Germany, France, and the U.K.) held larger shares in the global life science and chemical instrumentation market in 2014, the Asia-Pacific region is poised to grow at the highest rate in the next five years. Factors such as strategic expansion by key market players in emerging Asian countries; growing pharmaceutical and biopharmaceutical industry; rising government investments in biomedical industry in China and Singapore, and extensive crop research in Asia to feed its increasing population are propelling the demand of the life science and chemical instrumentations in Asia-Pacific region.

The growth of the global life science and chemical instrumentation market is driven by factors such as rising pharmaceutical R&D investments in emerging countries, increasing food safety concerns, availability of public and private funding for life science research studies, advancements in analytical instruments in terms of technology, miniaturization of instruments, and stringent drug development regulations in developed countries. In addition, emerging economies and increasing demand of analytical instruments from applied markets are creating new growth opportunities for the life science and chemical instrumentation manufacturers. Nonetheless, the high cost of technologically advanced instruments, scarcity of skilled professionals, and presence of alternative analytical technologies are the key reasons hampering the growth of life science and chemical instrumentation market.

In this report, the life science and chemical instrumentation market has been segmented on the basis of technology (covering chromatography, electrophoresis, DNA sequencers & amplifiers, lab automation, spectroscopy, immunoassay, microarray, flow cytometry, and other instruments (incubators, lab balances, fume hoods, and centrifuges)), by end user (including pharmaceutical, biopharmaceutical, and biotechnology companies; clinical research organizations (CROs); research institutions; hospitals, clinics, and diagnostic laboratories; academic institutions; forensic science laboratories; food and agriculture industry; and environmental testing industry; among others), and by region (North America, Europe, Asia Pacific, and Rest of the World). The spectroscopy market commanded the largest share of the global life science and chemical instrumentation market in 2014. However, the DNA sequencers and amplifiers market is expected to grow at the highest rate during the forecast period. Development of technologically advanced cost efficient genome sequencers and amplifiers is the key factor driving the growth of this market segment.

Geographically, North America (comprising the U.S. and Canada) commanded the largest share of the global life science and chemical instrumentation market in 2014, followed by Europe. The North American life science and chemical instrumentation market is driven by factors such as stringent drug development regulations, public and private funding for life science research activities, growing number of metabolomics research studies, rising prevalence of chronic diseases and aging population (that is responsible for the boost in the research on bio-based drugs), and a significant number of conferences, discussions, symposium, & seminars hosted by North America related to analytical technologies. However, increasing outsourcing of clinical research by big U.S. pharma companies to developing Asian countries and changes in the Canadian R&D tax credit program are negatively affecting the growth of the life science and chemical instrumentation market in North America.

The global life science and chemical instrumentation market is fragmented and competitive with a large number of global and local manufacturers of analytical instruments. Agilent Technologies, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Illumina, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Shimadzu Corporation (Japan), Thermo Fisher Scientific, Inc. (U.S.), and Waters Corporation (U.S.) are some of the key players in the global life science and chemical instrumentation market. New product launches, partnerships, agreements, collaborations, and geographic expansions were the major strategies adopted by most of the market players to achieve growth in the life science and chemical instrumentation market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis —industry analysis (industry trends, and Porter’s five force model), market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the life science and chemical instrumentation market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on analytical instrumentation products offered by the top 10 players in the life science and chemical instrumentation market. The report analyzes the life science and chemical instrumentation market by technology and end user across four geographies

- Product Development/Innovation: Detailed insights on current and upcoming technologies, research and development activities, and new product launches in the life science and chemical instrumentation market

- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various life science and chemical instrumentations across geographies

- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the life science and chemical instrumentation market

- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the life science and chemical instrumentation market

Table Of Contents

Life Science and Chemical Instrumentation Market - Global Forecast to 2019
TABLE OF CONTENTS

1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.3 MARKET SCOPE 24
1.3.1 MARKETS COVERED 24
1.3.2 YEARS CONSIDERED FOR THE STUDY 27
1.4 CURRENCY 27
1.5 STAKEHOLDERS 27
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH DATA 28
2.1.1 SECONDARY DATA 28
2.1.1.1 Key data from secondary sources 29
2.1.1 PRIMARY DATA 29
2.1.1.1 Breakdown of primaries 30
2.1.1.2 Key data from primary sources 30
2.1.1.3 Key industry insights 31
2.2 MARKET SIZE ESTIMATION 31
2.2.1.1 Bottom-up approach 32
2.2.1.2 Top-down approach 32
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 33
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS 35
2.4.1 ASSUMPTIONS 35
2.4.2 LIMITATIONS 35
3 EXECUTIVE SUMMARY 36
3.1 INTRODUCTION 36
3.2 CURRENT SCENARIO 37
3.3 FUTURE OUTLOOK 38
3.4 CONCLUSION 40
4 PREMIUM INSIGHTS 41
4.1 ATTRACTIVE OPPORTUNITIES IN THE LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET 41
4.2 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET GROWTH RATE, BY TECHNOLOGY AND REGION (2014-2019) 42
4.3 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY TECHNOLOGY AND REGION, 2014 ($MILLION) 43
4.4 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY TECHNOLOGY, 2012-2019 ($MILLION) 44
5 MARKET OVERVIEW 45
5.1 INTRODUCTION 46
5.2 MARKET SEGMENTATION 46
5.2.1 BY TECHNOLOGY 47
5.2.2 BY END USER 47
5.3 MARKET DYNAMICS 48
5.3.1 DRIVERS 49
5.3.1.1 Increasing government spending on pharmaceutical RandD in emerging nations 49
5.3.1.2 Growing food safety concerns 50
5.3.1.3 Technological advancements in analytical devices 50
5.3.1.4 Funding sources increase the purchasing power of major research institutions 51
5.3.2 RESTRAINTS 52
5.3.2.1 High cost of instruments 52
5.3.2.2 Presence of alternative technologies 52
5.3.3 OPPORTUNITIES 53
5.3.3.1 Emerging markets offering lucrative growth opportunities 53
5.3.3.2 Growing proteomics market 53
5.3.3.3 Growing environmental safety concerns 54
5.3.3.4 Increasing demand from applied markets 55
5.3.3.5 Opportunity for lab automation solutions in biobank applications 55
5.3.4 CHALLENGES 56
5.3.4.1 Extensive requirements in developing chromatography systems that generate pressures of above 20,000 psi 56
5.3.4.2 Survival of small players in the lab automation market 56
5.3.4.3 Adoption and implementation of MIQE guidelines for publishing qPCR- and dPCR-based research 56
6 INDUSTRY INSIGHTS 57
6.1 INTRODUCTION 57
6.2 VALUE CHAIN ANALYSIS 57
6.3 INDUSTRY TRENDS 58
6.3.1 RISING FOCUS OF MARKET PLAYERS TOWARDS THE DEVELOPMENT OF MINIATURIZED INSTRUMENTS 58
6.3.2 INCREASING ADOPTION OF HYPHENATED TECHNOLOGIES 58
6.3.3 TIE-UPS BETWEEN ANALYTICAL INSTRUMENT MANUFACTURERS AND RESEARCH LABORATORIES/ACADEMIC INSTITUTIONS 59
6.4 PORTER'S FIVE FORCES ANALYSIS 59
6.4.1 THREAT OF NEW ENTRANTS 60
6.4.2 THREAT FROM SUBSTITUTES 61
6.4.3 BARGAINING POWER OF SUPPLIERS 61
6.4.4 BARGAINING POWER OF BUYERS 61
6.4.5 INTENSITY OF COMPETITIVE RIVALRY 62
7 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY TECHNOLOGY 63
7.1 INTRODUCTION 64
7.2 CHROMATOGRAPHY 65
7.2.1 DRIVERS 66
7.2.1.1 New international GMP and GDP certification for pharmaceutical excipients (North America and Europe): EXCiPACT 66
7.2.1.2 Industry support to research laboratories and academic institutes 67
7.2.1.3 Rise in government investments in chromatography technologies 67
7.2.1.4 Increased importance of chromatography tests in drug approvals 67
7.2.2 RESTRAINT 68
7.2.2.1 High cost of instruments 68
7.2.3 CHALLENGE 68
7.2.3.1 Obtaining identical results from UHPLC after transfer of HPLC to UHPLC 68
7.2.4 CHROMATOGRAPHY MARKET, BY TYPE 69
7.2.4.1 Liquid chromatography 69
7.2.4.2 Gas chromatography 70
7.2.4.3 Other chromatography techniques 71
7.2.5 MARKET SHARE ANALYSIS, BY KEY PLAYER 72
7.3 ELECTROPHORESIS 72
7.3.1 DRIVERS 74
7.3.1.1 Preferred technique for fragile molecules and variants 74
7.3.1.2 Increase in demand for 2D gel electrophoresis 74
7.3.1.3 Lab-on-a-Chip (LOC) technology 74
7.3.2 RESTRAINT 74
7.3.2.1 Alternative technologies provide better results 74
7.3.3 ELECTROPHORESIS MARKET, BY TYPE 75
7.3.3.1 Gel electrophoresis 75
7.3.3.2 Capillary electrophoresis 75
7.4 DNA SEQUENCERS and AMPLIFIERS 76
7.4.1 DRIVERS 77
7.4.1.1 Technological advancements 77
7.4.1.2 Increasing public and private investments, funds, and grants 78
7.4.1.3 Rising incidence of infectious diseases and genetic disorders 78
7.4.2 RESTRAINTS 79
7.4.2.1 High cost of equipment 79
7.4.3 DNA SEQUENCERS and AMPLIFIERS MARKET, BY TYPE 80
7.4.3.1 DNA sequencers 80
7.4.3.1.1 Market share analysis, by key player 81
7.4.3.2 DNA amplifiers 81
7.4.3.2.1 Thermal Cyclers 82
7.4.3.2.2 Real-time PCR 83
7.4.3.2.3 Others 83
7.5 LAB AUTOMATION 84
7.5.1 DRIVERS 86
7.5.1.1 Process miniaturization leading to low reagent cost and high productivity 86
7.5.1.2 Progress in drug discovery and clinical diagnostics 86
7.5.1.3 Large workforce demand and supply gap 87
7.5.1.4 Greater productivity and reduction in costs 87
7.5.1.5 Smaller volumes of samples and reagents required 87
7.5.2 RESTRAINTS 87
7.5.2.1 Automation not a priority for small- and medium-sized labs 87
7.5.2.2 Indefinite data interchange/communication standards 87
7.5.3 LAB AUTOMATION MARKET, BY TYPE 88
7.5.3.1 Automatic liquid handling 88
7.5.3.2 Microplate readers 88
7.5.3.3 Standalone robots 89
7.5.3.4 Automated storage and retrieval systems 90
7.5.3.5 Software and informatics 90
7.5.3.6 Others 92
7.5.4 MARKET SHARE ANALYSIS, BY KEY PLAYER 93
7.6 SPECTROSCOPY 93
7.6.1 DRIVERS 95
7.6.1.1 Global alliances amongst leading research institutes to boost drug discovery 95
7.6.1.2 Atomic absorption spectroscopy to aid in the drug safety process 95
7.6.1.3 Increasing life science RandD spending 95
7.6.2 RESTRAINTS 96
7.6.2.1 High costs restrict purchase 96
7.6.2.2 Need for skilled professionals 96
7.6.3 SPECTROSCOPY MARKET, BY TYPE 96
7.6.3.1 Molecular spectroscopy 96
7.6.3.1.1 Market share analysis, by key player 97
7.6.3.2 Atomic spectroscopy 97
7.6.3.2.1 Market share analysis, by key player 98
7.6.3.3 Mass spectrometry 99
7.6.3.3.1 Market share analysis, by key player 99
7.7 IMMUNOASSAY 100
7.7.1 DRIVERS 102
7.7.1.1 Rising incidence of chronic and infectious diseases in emerging economies 102
7.7.1.2 Increasing number of approvals for immunoassay techniques 104
7.7.1.3 Advantages such as high sensitivity, low cost, and faster turnaround times 104
7.7.1.4 Increasing health awareness 105
7.7.2 RESTRAINTS 105
7.7.2.1 Low detection restricts adoption of immunoassay tests 105
7.7.2.2 Pricing pressure for some tests due to competition from lower cost-per-test technologies 105
7.7.3 IMMUNOASSAY MARKET, BY TYPE 105
7.7.3.1 Enzyme immunoassay (EIA) 105
7.7.3.2 Fluorescence immunoassay (FIA) 106
7.7.3.3 Chemiluminescence immunoassay (CLIA) 107
7.7.3.4 Radioimmunoassay (RIA) 107
7.7.3.5 Others 108
7.7.4 MARKET SHARE ANALYSIS, BY KEY PLAYER 109
7.8 MICROARRAY 110
7.8.1 DRIVERS AND OPPORTUNITIES 111
7.8.1.1 Growth in personalized medicine 111
7.8.1.2 Technological advances 111
7.8.1.3 Increasing application areas 111
7.8.2 RESTRAINT 112
7.8.2.1 Lack of technical know-how 112
7.8.3 MICROARRAYS MARKET, BY TYPE 112
7.8.3.1 DNA microarrays 112
7.8.3.2 Protein microarrays 112
7.8.3.3 Tissue microarrays 113
7.8.3.4 Cell microarrays 113
7.9 FLOW CYTOMETRY 114
7.9.1 DRIVERS 116
7.9.1.1 Technological advancements in flow cytometry instruments 116
7.9.1.2 Fostering use of flow cytometry techniques in research activities 116
7.9.1.3 Increasing use of flow cytometry in clinical trials 117
7.9.1.4 Increasing use of flow cytometry in HIV and cancer research 117
7.9.1.5 Launch of new reagents for specific applications like diagnostics and drug discovery 117
7.9.2 RESTRAINTS 118
7.9.2.1 High cost of instruments 118
7.9.2.2 Reluctance among researchers in emerging countries to use flow cytometry 118
7.9.2.3 Lack of awareness and dearth of training 118
7.9.3 FLOW CYTOMETRY MARKET, BY TYPE 118
7.9.3.1 Cell-based flow cytometry 118
7.9.3.2 Bead-based flow cytometry 119
7.9.3.3 Others 120
7.9.4 MARKET SHARE ANALYSIS, BY KEY PLAYER 121
7.10 OTHER INSTRUMENTS 121
7.10.1 CENTRIFUGES 122
7.10.2 LABORATORY BALANCES 123
7.10.2.1 Driver 123
7.10.2.1.1 Technological advancements in laboratory balances 123
7.10.2.2 Challenge 123
7.10.2.2.1 Effect of environmental disturbances 123
7.10.3 INCUBATORS 124
7.10.3.1 Drivers 124
7.10.3.1.1 Genetic engineering will drive the market 124
7.10.3.1.2 Stem cells and biological therapeutics increase the demand for CO2 incubators 124
7.10.3.2 Challenge 124
7.10.3.2.1 Contamination - A Major Concern 124
7.10.4 FUME HOODS 125
7.10.4.1 Driver 125
7.10.4.1.1 Improvements in device structure 125
7.10.4.2 Restraint 125
7.10.4.2.1 High electricity consumption 125
8 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY END USER 126
8.1 INTRODUCTION 127
8.2 CHROMATOGRAPHY 127
8.2.1 PHARMACEUTICAL COMPANIES AND CROS 129
8.2.2 BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANIES 129
8.2.3 ACADEMIC RESEARCH LABORATORIES 130
8.2.4 AGRICULTURE and FOOD INDUSTRY 131
8.2.5 ENVIRONMENTAL TESTING 131
8.2.6 OTHERS 132
8.3 ELECTROPHORESIS 132
8.3.1 PHARMACEUTICAL COMPANIES AND CROS 133
8.3.2 BIOTECHNOLOGY COMPANIES AND LIFE SCIENCE RESEARCH INSTITUTIONS 133
8.3.3 FORENSIC SCIENCE AND CLINICAL DIAGNOSTIC LABORATORIES 134
8.3.4 ACADEMIC INSTITUTIONS 134
8.3.5 OTHERS 134
8.4 DNA SEQUENCERS and AMPLIFIERS 135
8.4.1 PHARMA and BIOTECH COMPANIES AND CROS 136
8.4.2 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES 136
8.4.3 HOSPITALS AND DIAGNOSTIC CENTERS 137
8.4.4 FORENSIC SCIENCE LABORATORIES 137
?
8.5 LAB AUTOMATION 137
8.5.1 PHARMA and BIOTECH COMPANIES AND CROS 139
8.5.2 HOSPITALS AND PRIVATE LABS 139
8.5.3 RESEARCH INSTITUTIONS 140
8.5.4 ACADEMIC INSTITUTIONS 140
8.6 SPECTROSCOPY 140
8.6.1 PHARMACEUTICAL COMPANIES AND CROS 142
8.6.2 BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANIES 142
8.6.3 ENVIRONMENTAL TESTING 143
8.6.4 FOOD AND BEVERAGE INDUSTRY 143
8.6.5 INDUSTRIAL CHEMISTRY 144
8.6.6 ACADEMIC INSTITUTIONS 144
8.6.7 OTHERS 145
8.7 IMMUNOASSAYS 145
8.7.1 HOSPITALS (PRIVATE/PUBLIC) 146
8.7.2 LABORATORIES (PRIVATE/PUBLIC) 146
8.7.3 PHARMACEUTICAL and BIOTECH COMPANIES AND CROS 147
8.7.4 ACADEMIC INSTITUTIONS 147
8.7.5 OTHERS 147
8.8 MICROARRAYS 148
8.8.1 PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY 149
8.8.2 RESEARCH LABORATORIES 149
8.8.3 DIAGNOSTIC LABORATORIES 149
8.8.4 ACADEMIC INSTITUTIONS 150
8.8.5 OTHERS 150
8.9 FLOW CYTOMETRY 150
8.9.1 COMMERCIAL ORGANIZATIONS 151
8.9.2 ACADEMIC INSTITUTIONS 151
8.9.3 HOSPITALS 152
8.9.4 CLINICAL TESTING LABS 152
8.9.5 MEDICAL SCHOOLS 153
8.10 OTHER INSTRUMENTATION 154
8.10.1 PHARMACEUTICAL and BIOPHARMACEUTICAL COMPANIES AND CROS 154
8.10.2 RESEARCH LABORATORIES 154
8.10.3 ACADEMIC INSTITUTIONS 154
8.10.4 OTHERS 154
9 GLOBAL LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET,
BY REGION 155
9.1 INTRODUCTION 156
9.2 NORTH AMERICA 158
9.2.1 FUNDING IN MEDICAL RESEARCH MAY DEVELOP NEW APPLICATION AREAS FOR ANALYTICAL TECHNOLOGIES 159
9.2.2 DRUG DEVELOPMENT REGULATIONS IN NORTH AMERICA 159
9.2.3 GROWING METABOLOMICS RESEARCH IN THE U.S. 160
9.2.4 CONFERENCES, DISCUSSIONS, SYMPOSIUMS, and SEMINARS 160
9.2.5 RISING PREVALENCE OF CHRONIC DISEASES AND AGING POPULATION 161
9.3 EUROPE 166
9.3.1 DIRECT AND INDIRECT FINANCIAL INVESTMENTS IN ANALYTICAL INSTRUMENTS 167
9.3.2 STRATEGIC ALLIANCES IN EUROPE TO TRIGGER THE GROWTH OF DRUG DISCOVERY 167
9.3.3 BURGEONING GROWTH OF THE EUROPEAN BIOSIMILARS MARKET 168
9.3.4 CONFERENCES AND SYMPOSIA 168
9.3.5 DEVELOPING PHARMACEUTICAL SECTOR IN RUSSIA 168
9.4 ASIA-PACIFIC 173
9.4.1 STRATEGIC EXPANSIONS BY KEY MARKET PLAYERS IN EMERGING ASIAN COUNTRIES 174
9.4.2 GROWING PHARMACEUTICAL INDUSTRY IN INDIA AND CHINA 174
9.4.3 EXTENSIVE CROP RESEARCH IN ASIA 175
9.4.4 GOVERNMENT INVESTMENTS IN THE BIOMEDICAL INDUSTRY IN CHINA 175
9.4.5 INFRASTRUCTURAL DEVELOPMENT IN VIETNAM 175
9.4.6 SINGAPORE, AN IMPORTANT MARKET FOR LIFE SCIENCE AND CHEMICAL INSTRUMENTATION 176
9.4.7 CONFERENCES, EXHIBITIONS, and MEETINGS ON ANALYTICAL INSTRUMENTS 176
9.5 REST OF THE WORLD 181
9.5.1 FLOURISHING BIOTECHNOLOGY and PHARMACEUTICAL MARKETS IN BRAZIL AND MEXICO 181
9.5.2 INCREASING RandD FUNDING IN THE LATIN AMERICAN REGION 181
9.5.3 HIGH PREVALENCE OF HIV IN AFRICAN REGION IS LIKELY TO OPEN NEW GROWTH POTENTIAL FOR THE LAB AUTOMATION, IMMUNOASSAY, AND PCR MARKETS 182
10 COMPETITIVE LANDSCAPE 187
10.1 INTRODUCTION 187
10.1.1 NEW PRODUCT LAUNCHES 189
10.1.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 190
10.1.3 EXPANSIONS 191
10.1.4 ACQUISITIONS 192
10.1.5 OTHER DEVELOPMENTS 193
11 COMPANY PROFILES 195
(Overview, Financials, Products and Services, Strategy, and Developments)*
11.1 INTRODUCTION 195
11.2 AGILENT TECHNOLOGIES, INC. 196
11.3 BECTON, DICKINSON AND COMPANY 204
11.4 BIO-RAD LABORATORIES, INC. 208
11.5 BRUKER CORPORATION 213
11.6 DANAHER CORPORATION 218
11.7 F. HOFFMANN-LA ROCHE LTD. 224
11.8 PERKINELMER, INC. 228
11.9 SHIMADZU CORPORATION 233
11.10 THERMO FISHER SCIENTIFIC, INC. 239
11.11 WATERS CORPORATION 247
*Details on Financials, Product and Services, Strategy, and Developments might not be captured in case of unlisted companies.
12 APPENDIX 253
12.1 INSIGHTS OF INDUSTRY EXPERTS 253
12.2 DISCUSSION GUIDE 254
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 256
12.4 AVAILABLE CUSTOMIZATIONS 256
12.5 RELATED REPORTS 257


LIST OF TABLES

TABLE 1 GLOBAL LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SIZE,
BY TECHNOLOGY, 2012-2019 ($MILLION) 64
TABLE 2 GLOBAL CHROMATOGRAPHY MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 65
TABLE 3 GLOBAL CHROMATOGRAPHY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 66
TABLE 4 LIQUID CHROMATOGRAPHY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 69
TABLE 5 GAS CHROMATOGRAPHY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 70
TABLE 6 OTHER CHROMATOGRAPHY TECHNIQUES MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 71
TABLE 7 GLOBAL ELECTROPHORESIS MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 73
TABLE 8 ELECTROPHORESIS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 73
TABLE 9 GEL ELECTROPHORESIS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 75
TABLE 10 CAPILLARY ELECTROPHORESIS MARKET SIZE, BY REGION, 2012- 2019 ($MILLION) 76
TABLE 11 GLOBAL DNA SEQUENCERS and AMPLIFIERS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 77
TABLE 12 GLOBAL DNA SEQUENCERS and AMPLIFIERS MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 77
TABLE 13 DNA SEQUENCERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 80
TABLE 14 GLOBAL DNA AMPLIFIERS MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 81
TABLE 15 DNA AMPLIFIERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 82
TABLE 16 THERMO CYCLERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 82
TABLE 17 REAL-TIME PCR MARKET SIZE, BY REGION, 2012- 2019 ($MILLION) 83
TABLE 18 OTHER AMPLIFIERS MARKET SIZE, BY REGION, 2012- 2019 ($MILLION) 84
TABLE 19 GLOBAL LAB AUTOMATION MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 85
TABLE 20 LAB AUTOMATION MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 86
TABLE 21 AUTOMATED LIQUID HANDLING MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 88
TABLE 22 MICROPLATE READERS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 89
TABLE 23 STANDALONE ROBOTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 89
TABLE 24 AUTOMATED STORAGE AND RETRIEVAL SYSTEMS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 90
TABLE 25 SOFTWARE AND INFORMATICS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 92
TABLE 26 OTHER LAB AUTOMATION EQUIPMENT AND SOFTWARE MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 92
TABLE 27 GLOBAL SPECTROSCOPY MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION) 94
TABLE 28 SPECTROSCOPY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 94
TABLE 29 MOLECULAR SPECTROSCOPY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 97
TABLE 30 ATOMIC SPECTROSCOPY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 98
TABLE 31 MASS SPECTROMETRY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 99
TABLE 32 IMMUNOASSAY MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION) 101
TABLE 33 IMMUNOASSAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 101
TABLE 34 ENZYME IMMUNOASSAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 106
TABLE 35 FLUORESCENCE IMMUNOASSAY MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 106
TABLE 36 CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 107
TABLE 37 RADIOIMMUNOASSAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 108
TABLE 38 OTHER IMMUNOASSAYS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 109
TABLE 39 GLOBAL MICROARRAY MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 110
TABLE 40 MICROARRAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 111
TABLE 41 DNA MICROARRAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 112
TABLE 42 PROTEIN MICROARRAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 113
TABLE 43 TISSUE MICROARRAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 113
TABLE 44 CELL MICROARRAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 114
TABLE 45 GLOBAL FLOW CYTOMETRY MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 115
TABLE 46 FLOW CYTOMETER ARRAY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 116
TABLE 47 CELL-BASED FLOW CYTOMETRY MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 119
TABLE 48 BEAD-BASED FLOW CYTOMETRY MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 120
TABLE 49 OTHER FLOW CYTOMETRY TECHNOLOGIES MARKET SIZE, BY REGION,
2012-2019 ($MILLION) 120
TABLE 50 GLOBAL OTHER INSTRUMENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 121
TABLE 51 OTHER INSTRUMENTS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 122
TABLE 52 CENTRIFUGES MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 122
TABLE 53 LABORATORY BALANCES MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 123
TABLE 54 INCUBATORS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 124
TABLE 55 FUME HOODS MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 125
TABLE 56 GLOBAL CHROMATOGRAPHY MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 128
TABLE 57 GLOBAL ELECTROPHORESIS MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 133
TABLE 58 GLOBAL DNA SEQUENCERS and AMPLIFIERS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 136
TABLE 59 GLOBAL LAB AUTOMATION MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 138
TABLE 60 GLOBAL SPECTROSCOPY MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 141
TABLE 61 GLOBAL IMMUNOASSAYS MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 146
TABLE 62 GLOBAL MICROARRAYS MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 148
TABLE 63 GLOBAL FLOW CYTOMETRY MARKET SIZE, BY END USER, 2012-2019 ($MILLION) 151
TABLE 64 GLOBAL OTHER INSTRUMENTATION MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 154
TABLE 65 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SIZE, BY REGION, 2012-2019 ($MILLION) 157
TABLE 66 NORTH AMERICA: LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION) 162
TABLE 67 NORTH AMERICA: CHROMATOGRAPHY MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 162
TABLE 68 NORTH AMERICA: ELECTROPHORESIS MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 163
TABLE 69 NORTH AMERICA: DNA SEQUENCERS and AMPLIFIERS MARKET SIZE,
BY TYPE, 2012-2019 ($MILLION) 163
TABLE 70 NORTH AMERICA: LAB AUTOMATION MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 163
TABLE 71 NORTH AMERICA: SPECTROSCOPY MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 164
TABLE 72 NORTH AMERICA: IMMUNOASSAYS MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 164
TABLE 73 NORTH AMERICA: MICROARRAYS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 165
TABLE 74 NORTH AMERICA: FLOW CYTOMETRY MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 165
TABLE 75 NORTH AMERICA: OTHER INSTRUMENTS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 165
TABLE 76 EUROPE: LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SIZE,
BY TECHNOLOGY, 2012-2019 ($MILLION) 169
TABLE 77 EUROPE: CHROMATOGRAPHY MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 169
TABLE 78 EUROPE: ELECTROPHORESIS MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 170
TABLE 79 EUROPE: DNA SEQUENCERS and AMPLIFIERS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 170
TABLE 80 EUROPE: LAB AUTOMATION MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 170
TABLE 81 EUROPE: SPECTROSCOPY MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 171
TABLE 82 EUROPE: IMMUNOASSAYS MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 171
TABLE 83 EUROPE: MICROARRAYS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 171
TABLE 84 EUROPE: FLOW CYTOMETRY MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 172
TABLE 85 EUROPE: OTHER INSTRUMENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 172
TABLE 86 ASIA-PACIFIC: LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SIZE,
BY TECHNOLOGY, 2012-2019 ($MILLION) 177
TABLE 87 ASIA-PACIFIC: CHROMATOGRAPHY MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 177
TABLE 88 ASIA-PACIFIC: ELECTROPHORESIS MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 178
TABLE 89 ASIA-PACIFIC: DNA SEQUENCERS and AMPLIFIERS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 178
TABLE 90 ASIA-PACIFIC: LAB AUTOMATION MARKET SIZE, BY PRODUCT,
2012-2019 ($MILLION) 178
TABLE 91 ASIA-PACIFIC: SPECTROSCOPY MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 179
TABLE 92 ASIA-PACIFIC: IMMUNOASSAYS MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 179
TABLE 93 ASIA-PACIFIC: MICROARRAYS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 180
TABLE 94 ASIA-PACIFIC: FLOW CYTOMETRY MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 180
TABLE 95 ASIA-PACIFIC: OTHER INSTRUMENTS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 180
TABLE 96 ROW: LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SIZE,
BY TECHNOLOGY, 2012-2019 ($MILLION) 182
TABLE 97 ROW: CHROMATOGRAPHY MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 183
TABLE 98 ROW: ELECTROPHORESIS MARKET SIZE, BY TECHNOLOGY,
2012-2019 ($MILLION) 183
TABLE 99 ROW: DNA SEQUENCERS and AMPLIFIERS MARKET SIZE, BY TYPE,
2012-2019 ($MILLION) 183
TABLE 100 ROW: LAB AUTOMATION MARKET SIZE, BY PRODUCT, 2012-2019 ($MILLION) 184
TABLE 101 ROW: SPECTROSCOPY MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION) 184
TABLE 102 ROW: IMMUNOASSAYS MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION) 185
TABLE 103 ROW: MICROARRAYS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 185
TABLE 104 ROW: FLOW CYTOMETRY MARKET SIZE, BY TECHNOLOGY, 2012-2019 ($MILLION) 185
TABLE 105 ROW: OTHER INSTRUMENTS MARKET SIZE, BY TYPE, 2012-2019 ($MILLION) 186
TABLE 106 TOP 5 NEW PRODUCT LAUNCHES, 2012-2014 189
TABLE 107 TOP 5 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012-2014 190
TABLE 108 TOP 5 GEOGRAPHICAL EXPANSIONS, 2012-2014 191
TABLE 109 TOP 5 ACQUISITIONS, 2012-2014 193
TABLE 110 TOP 5 OTHER DEVELOPMENTS, 2012-2014 194


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 28
FIGURE 2 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS:
BY COMPANY TYPE, DESIGNATION, and REGION 30
FIGURE 3 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET:
BOTTOM-UP APPROACH 32
FIGURE 4 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET: TOP-DOWN APPROACH 33
FIGURE 5 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET: DATA TRIANGULATION 34
FIGURE 6 GLOBAL LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, 2014 ($MILLION) 36
FIGURE 7 GLOBAL LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET,
BY TECHNOLOGY, 2014 VS. 2019 38
FIGURE 8 GLOBAL LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY REGION, 2014 ($MILLION) 39
FIGURE 9 EMERGING COUNTRIES OFFER HIGH GROWTH OPPORTUNITIES TO PLAYERS IN THE LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET 41
FIGURE 10 ASIA-PACIFIC DNA SEQUENCERS AND AMPLIFIERS MARKET OFFERS LUCRATIVE GROWTH OPPORTUNITIES FOR PLAYERS 42
FIGURE 11 SPECTROSCOPY DOMINATES THE GLOBAL LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET ACROSS ALL GEOGRAPHIC REGIONS 43
FIGURE 12 SPECTROSCOPY SEGMENT WILL CONTINUE TO DOMINATE THE LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET IN 2019 44
FIGURE 13 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SEGMENTATION 46
FIGURE 14 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY TECHNOLOGY 47
FIGURE 15 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SEGMENTATION,
BY END USER 48
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, and CHALLENGES 49
FIGURE 17 INCREASING GOVERNMENT SPENDING ON PHARMACEUTICAL RandD IN EMERGING NATIONS IS PROPELLING THE MARKET GROWTH 51
FIGURE 18 HIGH COST OF TECHNOLOGICALLY ADVANCED INSTRUMENTS LIMITS THEIR ADOPTION AMONG LOW-BUDGET END USERS 53
FIGURE 19 EMERGING COUNTRIES ARE OFFERING LUCRATIVE GROWTH OPPORTUNITIES FOR MARKET PLAYERS 55
FIGURE 20 VALUE CHAIN OF LIFE SCIENCE AND CHEMICAL INSTRUMENTATION INDUSTRY 58
FIGURE 21 PORTER'S FIVE FORCES ANALYSIS 60
FIGURE 22 LIQUID CHROMATOGRAPHY SEGMENT ACCOUNTED FOR THE LION'S SHARE OF THE GLOBAL CHROMATOGRAPHY MARKET IN 2014 65
FIGURE 23 GLOBAL CHROMATOGRAPHY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2014 72
FIGURE 24 GEL ELECTROPHORESIS HELD THE LARGEST SHARE OF THE GLOBAL ELECTROPHORESIS MARKET IN 2014 73
FIGURE 25 DNA SEQUENCERS AND AMPLIFIERS MARKET IS POISED TO GROW AT A DOUBLE-DIGIT CAGR FROM 2014 TO 2019 76
FIGURE 26 BURGEONING PREVALENCE OF HIV WORLDWIDE WILL BOOST THE ADOPTION OF PCR 79
FIGURE 27 GLOBAL DNA SEQUENCERS MARKET SHARE, BY KEY PLAYER, 2014 81
FIGURE 28 MICROPLATE READERS ARE THE FASTEST-GROWING SEGMENT IN THE GLOBAL LAB AUTOMATION MARKET 85
FIGURE 29 INFORMATION FLOW PYRAMID 91
FIGURE 30 GLOBAL LAB AUTOMATION MARKET SHARE, BY KEY PLAYER, 2014 93
FIGURE 31 MOLECULAR SPECTROSCOPY SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL SPECTROSCOPY MARKET IN 2019 93
FIGURE 32 GLOBAL MOLECULAR SPECTROSCOPY MARKET SHARE, BY KEY PLAYER, 2014 97
FIGURE 33 GLOBAL ATOMIC SPECTROSCOPY MARKET SHARE, BY KEY PLAYER, 2014 98
FIGURE 34 GLOBAL MASS SPECTROMETRY MARKET SHARE, BY KEY PLAYER, 2014 100
FIGURE 35 ENZYME IMMUNOASSAYS SEGMENT DOMINATED THE GLOBAL IMMUNOASSAY MARKET IN 2014 100
FIGURE 36 GLOBAL PREVALENCE OF CANCER 102
FIGURE 37 GLOBAL DISTRIBUTION OF CARDIOVASCULAR MORTALITY RATES AMONG MALES, 2011 103
FIGURE 38 GLOBAL DISTRIBUTION OF CARDIOVASCULAR MORTALITY RATES AMONG FEMALES, 2011 104
FIGURE 39 GLOBAL IMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2014 109
FIGURE 40 OVER 50% OF THE MICROARRAY MARKET WAS DOMINATED BY DNA MICROARRAYS IN 2014 110
FIGURE 41 CELL-BASED FLOW CYTOMETRY SEGMENT DOMINATES THE FLOW CYTOMETRY MARKET 115
FIGURE 42 GLOBAL FLOW CYTOMETRY MARKET SHARE, BY KEY PLAYER, 2014 121
FIGURE 43 PHARMACEUTICAL COMPANIES AND CROS HOLD THE LARGEST SHARE OF CHROMATOGRAPHY END USERS MARKET 128
FIGURE 44 FORENSIC SCIENCE AND CLINICAL DIAGNOSTIC LABORATORIES ARE THE MAJOR END USERS OF ELECTROPHORESIS DEVICES 132
FIGURE 45 HOSPITALS AND DIAGNOSTIC CENTERS ARE THE FASTEST-GROWING END-USER SEGMENT OF THE DNA SEQUENCERS AND AMPLIFIERS MARKET 135
FIGURE 46 THE ADOPTION OF LAB AUTOMATION SOLUTIONS IS INCREASING RAPIDLY AMONG RESEARCH INSTITUTIONS 138
FIGURE 47 PHARMACEUTICAL COMPANIES AND CROS COMMAND THE LARGEST SHARE OF THE GLOBAL SPECTROSCOPY END USERS MARKET 141
FIGURE 48 HOSPITALS ARE THE MAJOR END USERS OF THE IMMUNOASSAYS MARKET 145
FIGURE 49 PHARMA AND BIOPHARMA INDUSTRIES DOMINATE THE MICROARRAY INSTRUMENTATION END USERS MARKET 148
FIGURE 50 CLINICAL TESTING LABS IS THE FASTEST-GROWING SEGMENT OF THE FLOW CYTOMETRY END USERS MARKET 150
FIGURE 51 ASIA-PACIFIC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 156
FIGURE 52 AVAILABILITY OF LIFE SCIENCE RESEARCH FUNDING IS DRIVING THE MARKET GROWTH 158
FIGURE 53 EUROPEAN LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SNAPSHOT (2014-2019): DIRECT AND INDIRECT INVESTMENTS IN ANALYTICAL INSTRUMENTS ARE DRIVING THE MARKET GROWTH 166
FIGURE 54 ASIA-PACIFIC LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET SNAPSHOT (2014-2019): KEY PLAYERS ARE STRATEGICALLY EXPANDING THEIR PRESENCE IN THIS EMERGING MARKET 173
FIGURE 55 LEADING MARKET PLAYERS ADOPTED NEW PRODUCT LAUNCHES AS THEIR KEY GROWTH STRATEGY IN 2014 188
FIGURE 56 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES IS THE KEY STRATEGY 189
FIGURE 57 GEOGRAPHIC REVENUE MIX OF TOP 5 MARKET PLAYERS 195
FIGURE 58 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT 196
FIGURE 59 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 204
FIGURE 60 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 208
FIGURE 61 BRUKER CORPORATION: COMPANY SNAPSHOT 213
FIGURE 62 DANAHER CORPORATION: COMPANY SNAPSHOT 218
FIGURE 63 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT 224
FIGURE 64 PERKINELMER, INC.: COMPANY SNAPSHOT 228
FIGURE 65 SHIMADZU CORPORATION: COMPANY SNAPSHOT 233
FIGURE 66 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT 239
FIGURE 67 WATERS CORPORATION: COMPANY SNAPSHOT 247

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

Life Science Instrumentation Market by Technology, End User, Application - Global Forecast to 2021

Life Science Instrumentation Market by Technology, End User, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global life science instrumentation market is estimated to grow at a CAGR of 6.8% from 2016 to 2021, to reach USD 64.52 billion by 2021. Factors such as increasing spending on pharmaceutical R&D, growing ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.